NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM171518 Query DataSets for GSM171518
Status Public on Feb 27, 2007
Title ID_22_TimePt_1
Sample type RNA
 
Source name Human PBMC collected from whole blood.
Organism Homo sapiens
Characteristics ID_22_TimePt_1_Race_AA_Resp_Poor
Treatment protocol The clinical protocol called for participants to be treated for up to 48 weeks with peginterferon alpha-2a (Pegasys™, Roche Pharmaceuticals Nutley, NJ) in a dose of 180 µg weekly by self-administered subcutaneous injection and ribavirin (Copegus™, Roche) orally in a dose of 1000 or 1200 mg daily based on body weight of less than 75 kg or equal to or greater than 75 kg.
Extracted molecule total RNA
Extraction protocol Samples were shipped overnight by express courier at 4 degrees C to a central repository where RNA was isolated on arrival The PBMC were lysed in 1 ml of TRI reagent (Molecular Research Center Inc: Cincinnati, OH). The PBMC lysate was mixed with 1-Bromo-3-chloropropane (BCP)-phase separation agent for 1 minute, and incubated at room temperature for 15 minutes. After centrifugation for 15 minutes at 12,000 rpm and 4 degrees C, RNA was precipitated from the supernatant overnight at -20 degrees C with an equal volume of isopropanol and 1/10 volume of 7.5 M-ammonium acetate. The precipitate was washed twice with 75% ethanol, and then with 95% ethanol. RNA was briefly air-dried and then further purified using RNeasy columns (Qiagen: Valencia, CA).
Label biotin
Label protocol Preparation of cDNA, cRNA, and labeling were carried out according to the protocols recommended by Affymetrix in the GeneChip® Expression Analysis Technical Manual (Affymetrix, Santa Clara, CA)
 
Hybridization protocol Following fragmentation, 15 microg of cRNA were mixed with spike controls and 2/3 was hybridized for 17 hr at 45C on GeneChip Human Genome 133A Array. GeneChips were washed and stained in the Affymetrix Fluidics Station per manufacturer's instructions.
Scan protocol The microarrays were scanned using a dedicated Model 3000 scanner controlled by GCOS software.
Description Gene Expression for human subject. Human PBMC collected from whole blood. PBMC were collected in sodium heparin-CPT tubes at day 0 (before treatment) and days 1, 2, 7, 14 and 28 after initiation of treatment. Whole blood was diluted with an equal volume (8 ml) of phosphate buffered saline (PBS), carefully layered over a 10 ml Ficoll-Hypaque gradient (Amersham/Pharmacia, Piscataway, NJ) and centrifuged at 800 rpm for 20 minutes at room temperature. The buffy coat layer was transferred to a 15ml RNAse-free tube, diluted with PBS, and centrifuged at 100 x g for 15 minutes at room temperature. The supernatants were discarded and the PBMC were retained.
Data processing GCOS was used for data processing. The average intensity on each array was normalized by global scaling to a target intensity of 1000. Data were extracted using the Affymetrix Microarray Suite 5 (MAS5) algorithm

CEL file unavailable due to computer disk failure
 
Submission date Feb 23, 2007
Last update date Mar 02, 2009
Contact name Milton W Taylor
E-mail(s) [email protected]
Organization name Indiana University
Department Biology
Street address 343 Jordan Hall
City Bloomington
State/province IN
ZIP/Postal code 47405
Country USA
 
Platform ID GPL96
Series (1)
GSE7123 Gene profiling of responders and non-responders to antiviral therapies peg interferon and ribavirin against hepatitis C

Data table header descriptions
ID_REF
VALUE MAS5-calculated Signal intensity
ABS_CALL the call in an absolute analysis that indicates if the transcript was present (P), absent (A), marginal (M), or no call (NC); default parameters.
DETECTION P-VALUE 'detection p-value', p-value that indicates the significance level of the detection call

Data table
ID_REF VALUE ABS_CALL DETECTION P-VALUE
AFFX-BioB-5_at 553.1 P 0.002023
AFFX-BioB-M_at 979.2 P 0.000052
AFFX-BioB-3_at 413.4 P 0.000258
AFFX-BioC-5_at 2338.5 P 0.00006
AFFX-BioC-3_at 2367.9 P 0.000044
AFFX-BioDn-5_at 2954 P 0.000044
AFFX-BioDn-3_at 11681.6 P 0.000081
AFFX-CreX-5_at 19054.7 P 0.000044
AFFX-CreX-3_at 27061.8 P 0.000044
AFFX-DapX-5_at 61.3 A 0.102165
AFFX-DapX-M_at 50.6 A 0.313723
AFFX-DapX-3_at 6.3 A 0.945802
AFFX-LysX-5_at 15.3 A 0.659339
AFFX-LysX-M_at 10 A 0.724854
AFFX-LysX-3_at 32.9 A 0.185131
AFFX-PheX-5_at 5.5 A 0.916408
AFFX-PheX-M_at 6.7 A 0.860518
AFFX-PheX-3_at 95.9 A 0.39692
AFFX-ThrX-5_at 12.5 A 0.904333
AFFX-ThrX-M_at 21.3 A 0.712257

Total number of rows: 22283

Table truncated, full table size 597 Kbytes.




Supplementary data files not provided

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap